Nsaid and h2 receptor antagonist combinations for the treatment of pain and inflammation
作者： Mehmet Nevzat Pisak
DOI:
关键词:
摘要: The present invention provides a pharmaceutical composition comprising at least one NSAIA that selectively inhibits COX-2 in combination with H2 receptor antagonist single unit dosage form. Pharmaceutical of the is useful for treatment inflammation and pain.
lens.org 参考文章(9)
Robert P. Nickell, Combined nsaid and acid blocker formulation and method ,(2008)
Ibrahim Mustafa Iskender Pisak, Mehmet Levent Selamoglu, Semra Bingol, Thiocolchicoside, etodolac and famotidine combinations ,(2012)
Barry L. Golombik, George Tidmarsh, Nsaid dose unit formulations with h2-receptor antagonists and methods of use ,(2007)
Elizabeth Vadas, Mark A. Goldsmith, James B. Tananbaum, Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors ,(2006)
Sabina De Geest, Eduardo Sabaté, Adherence to Long-Term Therapies: Evidence for Action: European Journal of Cardiovascular Nursing. ,vol. 2, pp. 323- 323 ,(2003) , 10.1016/S1474-5151(03)00091-4
John R. Plachetka, Pharmaceutical compositions for the coordinated delivery of NSAIDs ,(2002)
William J. Goldman, Thomas N. Gates, Pharmaceutical compositions and methods for treating the symptoms of overindulgence ,(1992)
Dacheng Tian, Xiu Cheng, Avinash Nangia, Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug ,(2005)
Mahmut Bilgic, Pharmaceutical compositions of s-etodolac ,(2013)